Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Buy
54
GCO Quote, Financials, Valuation and Earnings
Last price:
$41.25
Seasonality move
:
11.55%
Day range:
$39.33 - $42.62
52-week range:
$23.21 - $44.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.19x
P/B ratio:
0.90x
Volume:
478.4K
Avg. volume:
182.6K
1-year change:
24.23%
Market cap:
$462.8M
Revenue:
$2.3B
EPS (TTM):
-$2.52
Analysts' Opinion
-
Consensus RatingGenesco has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Genesco has an estimated downside of -3.1% from its current price of $41.28.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $41.28.
Fair Value
-
According to the consensus of 0 analysts, Genesco has -3.1% downside to fair value with a price target of -- per share.
GCO vs. S&P 500
-
Over the past 5 trading days, Genesco has underperformed the S&P 500 by -2.49% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Genesco does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Genesco has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Genesco reported revenues of $596.3M.
Earnings Growth
-
Genesco earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Genesco reported earnings per share of -$1.76.
Enterprise value:
530.2M
EV / Invested capital:
0.86x
Price / LTM sales:
0.19x
EV / EBIT:
113.05x
EV / Revenue:
0.23x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
10.34x
Price / Operating cash flow:
8.76x
Enterprise value / EBITDA:
9.12x
Gross Profit (TTM):
$1.1B
Return On Assets:
-1.88%
Net Income Margin (TTM):
-1.13%
Return On Equity:
-4.82%
Return On Invested Capital:
-4.2%
Operating Margin:
1.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Income Statement | ||||||
| Revenue | $2.4B | $2.3B | $2.3B | $579.3M | $596.3M | |
| Gross Profit | $1.2B | $1.1B | $1.1B | $278.4M | $285.3M | |
| Operating Income | $108.5M | $29.1M | $7.8M | $11M | $10.3M | |
| EBITDA | $169.1M | $45M | $58.1M | $23M | $23.2M | |
| Diluted EPS | $7.02 | -$0.58 | -$2.52 | $0.60 | -$1.76 | |
| Period Ending | 2020-10-31 | 2021-10-31 | 2022-10-31 | 2023-10-31 | 2024-10-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $584M | $744.4M | $681.8M | $638.7M | $659.7M | |
| Total Assets | $1.5B | $1.6B | $1.5B | $1.5B | $1.4B | |
| Current Liabilities | $432.6M | $474M | $445.4M | $397.2M | $422.1M | |
| Total Liabilities | $1.1B | $1B | $977.7M | $956M | $918.6M | |
| Total Equity | $470M | $592.4M | $559.3M | $537M | $516.9M | |
| Total Debt | $32.9M | $15.6M | $89.4M | $128.2M | $100.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-10-31 | 2023-10-31 | 2024-10-31 | 2023-10-31 | 2024-10-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$156.2M | $55.5M | $89.2M | $1.6M | -$23.1M | |
| Cash From Investing | -$39.3M | -$69.7M | -$37.7M | -$14.4M | -$13.1M | |
| Cash From Financing | -$52.1M | $3.3M | -$40.2M | -$1.9M | $23.6M | |
| Free Cash Flow | -$215.5M | -$14.3M | $51.3M | -$12.8M | -$36.2M | |
GCO
Sector
Market Cap
$462.8M
$483.3M
Price % of 52-Week High
92.14%
72.36%
Dividend Yield
0%
0%
Shareholder Yield
--
3.61%
1-Year Price Total Return
24.23%
-11.07%
Beta (5-Year)
2.475
0.973
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$42.45
200-day SMA
Buy
Level
$28.36
Bollinger Bands (100)
Buy
Level
25.31 - 35.29
Chaikin Money Flow
Buy
Level
43M
20-day SMA
Buy
Level
$39.06
Relative Strength Index (RSI14)
Buy
Level
63.18
ADX Line
Sell
Level
7.14
Williams %R
Neutral
Level
-34.476
50-day SMA
Buy
Level
$32.69
MACD (12, 26)
Buy
Level
2.96
25-day Aroon Oscillator
Buy
Level
76
On Balance Volume
Neutral
Level
58.9M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.4482)
Buy
CA Score
(Annual)
Level (-0.2087)
Buy
Beneish M-Score
(Annual)
Level (-2.6551)
Buy
Momentum Score
Level (5)
Buy
Ohlson Score
Level (-1.9579)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Genesco Inc sells footwear, headwear, sports apparel, and accessories. The company has four reportable segments namely Journeys Group, derives maximum revenue which comprised of Journeys, Journeys Kidz, and Little Burgundy retail footwear chains, e-commerce operations, and catalog. Its Schuh Group is comprised of the Schuh retail footwear chain and e-commerce operations. The Johnston & Murphy Group is comprised of Johnston & Murphy retail operations, e-commerce operations, and catalog and wholesale distribution of products under the Johnston & Murphy and Genesco Brands Group. Licensed Brands, comprised of Dockers Footwear, under a license from Levi Strauss & Company.
Stock Forecast FAQ
In the current month, GCO has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GCO average analyst price target in the past 3 months is --.
-
Where Will Genesco Stock Be In 1 Year?
According to analysts, the consensus estimate is that Genesco share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Genesco?
Analysts are divided on their view about Genesco share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Genesco is a Sell and believe this share price will rise from its current level to --.
-
What Is Genesco's Price Target?
The price target for Genesco over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GCO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Genesco is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of GCO?
You can purchase shares of Genesco via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Genesco shares.
-
What Is The Genesco Share Price Today?
Genesco was last trading at $41.25 per share. This represents the most recent stock quote for Genesco. Yesterday, Genesco closed at $41.28 per share.
-
How To Buy Genesco Stock Online?
In order to purchase Genesco stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
